Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis
- PMID: 19053950
- DOI: 10.1111/j.1600-0404.2008.01133.x
Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis
Abstract
Objectives: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease. There is evidence that oxidative stress is implicated in the pathophysiology of the neurodegenerative disorders, including ALS. Data from the literature suggests that the receptor for advanced glycation end products (RAGE) participates in pathological conditions, including oxidative stress and neurodegeneration.
Materials and methods: The study involved 20 patients with ALS and 20 patients from the control group. The serum-soluble RAGE (sRAGE) levels were measured using the enzyme-linked immunosorbent method.
Results: The study showed that sRAGE levels are significantly decreased in serum of the patients with ALS comparing to the control group (P < 0.05). The correlation between the serum sRAGE levels and clinical parameters of the disease was not significant (P > 0.05).
Conclusions: The results indicate that sRAGE participates in pathophysiology of the ALS. It is possible that low sRAGE levels may influence neurodegeneration.
Comment in
-
Serum sRAGE levels in amyotrophic lateral sclerosis.Acta Neurol Scand. 2010 Feb;121(2):139. doi: 10.1111/j.1600-0404.2009.01300.x. Epub 2009 Nov 23. Acta Neurol Scand. 2010. PMID: 19930208 No abstract available.
Similar articles
-
Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.Mult Scler. 2008 Jul;14(6):759-63. doi: 10.1177/1352458507088105. Epub 2008 May 27. Mult Scler. 2008. PMID: 18505774
-
Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.Acta Neurol Scand. 2008 May;117(5):343-6. doi: 10.1111/j.1600-0404.2007.00947.x. Epub 2007 Nov 8. Acta Neurol Scand. 2008. PMID: 17995989
-
Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.Metabolism. 2007 Feb;56(2):199-205. doi: 10.1016/j.metabol.2006.09.013. Metabolism. 2007. PMID: 17224333
-
Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.Neuroimmunomodulation. 2007;14(3-4):163-7. doi: 10.1159/000110641. Epub 2007 Dec 5. Neuroimmunomodulation. 2007. PMID: 18073509
-
RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis.Neurosci Biobehav Rev. 2016 Mar;62:48-55. doi: 10.1016/j.neubiorev.2015.12.006. Epub 2015 Dec 25. Neurosci Biobehav Rev. 2016. PMID: 26724598 Review.
Cited by
-
Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.Front Cell Neurosci. 2016 May 9;10:117. doi: 10.3389/fncel.2016.00117. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27242430 Free PMC article.
-
Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.Curr Drug Targets. 2022;23(12):1191-1209. doi: 10.2174/1389450123666220610171005. Curr Drug Targets. 2022. PMID: 35702767 Free PMC article.
-
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.Curr Neuropharmacol. 2023;21(2):219-234. doi: 10.2174/1570159X20666220922153903. Curr Neuropharmacol. 2023. PMID: 36154605 Free PMC article. Review.
-
Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis.AIMS Neurosci. 2022 Nov 10;9(4):423-443. doi: 10.3934/Neuroscience.2022023. eCollection 2022. AIMS Neurosci. 2022. PMID: 36660079 Free PMC article. Review.
-
Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis.Front Cell Neurosci. 2015 Dec 22;9:485. doi: 10.3389/fncel.2015.00485. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26733811 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
